tirzepatide weight loss nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and Obesity (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy Weight Regain after Stopping Obesity

When consumers stop a GLP-1 drug, the health benefits experienced are often eroded: a preliminary study showed that those who stopped taking GLP-1 prescriptions on average gained two thirds of lost weight back, diminishing the health benefits of the drugs over time

The goal isnt just a smaller body

Groundbreaking Research: Real Results from Real Patients A recent study conducted at the Institute for Hormonal Balance in Orlando, Florida, examined the effects of BPC-157 injections directly into the knee joint

S.SriRamaratnamR.WelschM

(2025) Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b study

Functionally, glutathione participates in a wide range of biochemical processes, including: Regulation of reactive oxygen species (ROS) Support of cellular detoxification mechanisms via conjugation pathways Maintenance of protein thiol status and intracellular redox signaling Involvement in mitochondrial function and metabolic regulation Due to its broad biological relevance, glutathione is extensively utilized in in vitro studies, oxidative stress models, and biochemical pathway research , particularly in fields such as molecular biology, toxicology, and cellular physiology